Formulation Facilities

1. HETERO DRUGS LTD.

    • Unit – IIIA (Jeedimetla):
      Finished dosage manufacturing facility for semi-regulatory markets – WHO Approved
    • Unit – IIIB (Jeedimetla):
      Finished dosage manufacturing facility for regulatory markets – USFDA Approved
    • Unit – V (Baddi):
      Finished dosage manufacturing facility for Indian market

    2. HETERO LABS LTD.

    • Unit – II (Baddi):
      Finished dosage manufacturing facility for semi-regulatory & Indian markets
    • Unit – V (Jedcherla):
      Solid & Liquid finished dosage manufacturing facility for semi-regulatory & regulatory markets
    • Unit – VI (Jedcherla):
      Dedicated Oncology finished dosage manufacturing facility for semi- regulatory & regulatory markets

    3. INVAGEN PHARMACEUTICALS INC., USA

    • Manufacturing facility for generic finished dosages
Manufacturing Infrastructure
Formulation Facilities